Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Company will seek strategic acquisition partner for clinical-stage pharma/med-tech operations.
Stuart D. Porter, founder of Denham Capital (over $12B committed), joins board effective May 29, 2026.
Strategy targets power equipment/services for hyperscale AI data centers; NERC projects 224 GW demand increase.
LIXT expects to maintain Nasdaq listing under ticker LIXT during transformation.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stuart D. Porter

Director

LIXT · LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Effective: 2026-05-29
Filed: June 1, 2026, 8:55 AM ET

On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stuart D. Porter was appointed as Director at LIXTE BIOTECHNOLOGY HOLDINGS, INC..

Action: appointed
Role: Director

Exact text from the filing

On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.

View on SEC.gov

LIXTE BIOTECHNOLOGY HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-26-026544

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.